Éva Bozó

Glycosylidene Carbenes. Part 14. Glycosidation of partially protected galactopyranose‐, glucopyranose‐, and mannopyranose‐derived vicinal diols

Pulla Reddy Muddasani, Éva Bozó, Bruno Bernet et al. · Helvetica Chimica Acta · 1994 · 54 citations

Life Sciences, Biochemistry, Chemistry +17

Oxamides as novel NR2B selective NMDA receptor antagonists

G. BARTA‐SZALAI, István Borza, Éva Bozó et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 45 citations · Full text

Medicine, Neuroscience, Pharmacology +7

Selective NR1/2B<i>N</i>-Methyl-<scp>d</scp>-aspartate Receptor Antagonists among Indole-2-carboxamides and Benzimidazole-2-carboxamides

István Borza, Éva Bozó, G. BARTA‐SZALAI et al. · Journal of Medicinal Chemistry · 2007 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

An economic synthesis of 1,2,3,4-tetra-O-acetyl-5-thio-d-xylopyranose and its transformation into 4-substituted-phenyl 1,5-dithio-d-xylopyranosides possessing antithrombotic activity11Orally active antithrombotic thioglycosides, Part V. For Part IV see[1].22Presented partly at the 9th European Carbohydrate Symposium, Utrecht, 6–11 July 1997, Abstr. A16.

Éva Bozó, Sándor Boros, János Kuszmann et al. · Carbohydrate Research · 1998 · 36 citations

Pharmacy, Biochemistry, Chemistry +5

Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists

István Borza, Sándor Kolok, Anikó Gere et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8